Genetics of primary hypertension: The clinical impact of adducin polymorphisms

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 12, 2010, Pages 1285-1298

  Citterio, Lorena ^a   Lanzani, Chiara ^a   Manunta, Paolo ^a   Bianchi, Giuseppe ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Complex disease; Hypertension phase; Network; Polymorphism

Indexed keywords

ADDUCIN; ADDUCIN 1; ADDUCIN 2; ADDUCIN 3; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; OUABAIN; PLACEBO; RENIN; ROSTAFUROXIN; UNCLASSIFIED DRUG;

ASIAN; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DNA POLYMORPHISM; GENE INTERACTION; GENE REGULATORY NETWORK; GENE STRUCTURE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENOMICS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM ABSORPTION; SPECIES DIFFERENCE;

ANIMALS; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; DIURETICS; HUMANS; HYPERTENSION; KIDNEY TUBULES; OUABAIN; POLYMORPHISM, GENETIC; SODIUM;

ANIMALIA; RODENTIA; STROPHANTHUS GRATUS;

EID: 78049275767     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.03.014     Document Type: Review

References (164)

1. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
2. Cowley A.W. The genetic dissection of essential hypertension. Nat. Rev. Genet. 2006, 7(11):829-840.
3. Luft F.C. Present status of genetic mechanisms in hypertension. Med. Clin. N. Am. 2004, 88:1-18.
4. Sober S., Org E., Kepp K., Juhanson P., Eyheramendy S., Gieger C., Lichtner P., Klopp N., Veldre G., Viigimaa M., Doring A., Putku M., Kelgo P., Shaw-Hawkins S., Howard P., Onipinla A., Dobson R.J., Newhouse S.J., Brown M., Dominiczak A., Connell J., Samani N., Farrall M., Caulfield M.J., Munroe P.B., Illig T., Wichmann H.E., Meitinger T., Laan M. Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PloS One 2009, 4:e6034.
5. Levy D., Ehret G.B., Rice K., Verwoert G.C., Launer L.J., Dehghan A., Glazer N.L., Morrison A.C., Johnson A.D., Aspelund T., Aulchenko Y., Lumley T., Kottgen A., Vasan R.S., Rivadeneira F., Eiriksdottir G., Guo X., Arking D.E., Mitchell G.F., Mattace-Raso F.U., Smith A.V., Taylor K., Scharpf R.B., Hwang S.J., Sijbrands E.J., Bis J., Harris T.B., Ganesh S.K., O'Donnell C.J., Hofman A., Rotter J.I., Coresh J., Benjamin E.J., Uitterlinden A.G., Heiss G., Fox C.S., Witteman J.C., Boerwinkle E., Wang T.J., Gudnason V., Larson M.G., Chakravarti A., Psaty B.M., van Duijn C.M. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 2009, 41:677-687.
6. Newton-Cheh C., Johnson T., Gateva V., Tobin M.D., Bochud M., Coin L., Najjar S.S., Zhao J.H., Heath S.C., Eyheramendy S., Papadakis K., Voight B.F., Scott L.J., Zhang F., Farrall M., Tanaka T., Wallace C., Chambers J.C., Khaw K.T., Nilsson P., van der Harst P., Polidoro S., Grobbee D.E., Onland-Moret N.C., Bots M.L., Wain L.V., Elliott K.S., Teumer A., Luan J., Lucas G., Kuusisto J., Burton P.R., Hadley D., McArdle W.L., Brown M., Dominiczak A., Newhouse S.J., Samani N.J., Webster J., Zeggini E., Beckmann J.S., Bergmann S., Lim N., Song K., Vollenweider P., Waeber G., Waterworth D.M., Yuan X., Groop L., Orho-Melander M., Allione A., Di Gregorio A., Guarrera S., Panico S., Ricceri F., Romanazzi V., Sacerdote C., Vineis P., Barroso I., Sandhu M.S., Luben R.N., Crawford G.J., Jousilahti P., Perola M., Boehnke M., Bonnycastle L.L., Collins F.S., Jackson A.U., Mohlke K.L., Stringham H.M., Valle T.T., Willer C.J., Bergman R.N., Morken M.A., Doring A., Gieger C., Illig T., Meitinger T., Org E., Pfeufer A., Wichmann H.E., Kathiresan S., Marrugat J., O'Donnell C.J., Schwartz S.M., Siscovick D.S., Subirana I., Freimer N.B., Hartikainen A.L., McCarthy M.I., O'Reilly P.F., Peltonen L., Pouta A., de Jong P.E., Snieder H., van Gilst W.H., Clarke R., Goel A., Hamsten A., Peden J.F., Seedorf U., Syvanen A.C., Tognoni G., Lakatta E.G., Sanna S., Scheet P., Schlessinger D., Scuteri A., Dorr M., Ernst F., Felix S.B., Homuth G., Lorbeer R., Reffelmann T., Rettig R., Volker U., Galan P., Gut I.G., Hercberg S., Lathrop G.M., Zelenika D., Deloukas P., Soranzo N., Williams F.M., Zhai G., Salomaa V., Laakso M., Elosua R., Forouhi N.G., Volzke H., Uiterwaal C.S., van der Schouw Y.T., Numans M.E., Matullo G., Navis G., Berglund G., Bingham S.A., Kooner J.S., Connell J.M., Bandinelli S., Ferrucci L., Watkins H., Spector T.D., Tuomilehto J., Altshuler D., Strachan D.P., Laan M., Meneton P., Wareham N.J., Uda M., Jarvelin M.R., Mooser V., Melander O., Loos R.J., Elliott P., Abecasis G.R., Caulfield M., Munroe P.B. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 2009, 41:666-676.
7. Cho Y.S., Go M.J., Kim Y.J., Heo J.Y., Oh J.H., Ban H.J., Yoon D., Lee M.H., Kim D.J., Park M., Cha S.H., Kim J.W., Han B.G., Min H., Ahn Y., Park M.S., Han H.R., Jang H.Y., Cho E.Y., Lee J.E., Cho N.H., Shin C., Park T., Park J.W., Lee J.K., Cardon L., Clarke G., McCarthy M.I., Lee J.Y., Lee J.K., Oh B., Kim H.L. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 2009, 41:527-534.
8. Org E., Eyheramendy S., Juhanson P., Gieger C., Lichtner P., Klopp N., Veldre G., Doring A., Viigimaa M., Sober S., Tomberg K., Eckstein G., Kelgo P., Rebane T., Shaw-Hawkins S., Howard P., Onipinla A., Dobson R.J., Newhouse S.J., Brown M., Dominiczak A., Connell J., Samani N., Farrall M., Caulfield M.J., Munroe P.B., Illig T., Wichmann H.E., Meitinger T., Laan M. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum. Mol. Genet. 2009, 18:2288-2296.
9. Wang Y., O'Connell J.R., McArdle P.F., Wade J.B., Dorff S.E., Shah S.J., Shi X., Pan L., Rampersaud E., Shen H., Kim J.D., Subramanya A.R., Steinle N.I., Parsa A., Ober C.C., Welling P.A., Chakravarti A., Weder A.B., Cooper R.S., Mitchell B.D., Shuldiner A.R., Chang Y.P. From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:226-231.
10. Bianchi G. Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289(6):R1536-R1549.
11. Scriver C.R., Waters P.J. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 1999, 15(7):267-272.
12. Weatherall D.J. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet. 2001, 2(4):245-255.
13. Chen Y., Zhu J., Lum P.Y., Yang X., Pinto S., MacNeil D.J., Zhang C., Lamb J., Edwards S., Sieberts S.K., Leonardson A., Castellini L.W., Wang S., Champy M.F., Zhang B., Emilsson V., Doss S., Ghazalpour A., Horvath S., Drake T.A., Lusis A.J., Schadt E.E. Variations in DNA elucidate molecular networks that cause disease. Nature 2008, 452(7186):429-435.
14. Phillips P.C. Epistasis-the essential role of gene interactions in the structure and evolution of genetic systems. Nat. Rev. Genet. 2008, 9(11):855-867.
15. Russell R.B., Aloy P. Targeting and tinkering with interaction networks. Nat. Chem. Biol. 2008, 4(11):666-673.
16. Shao H., Burrage L.C., Sinasac D.S., Hill A.E., Ernest S.R., O'Brien W., Courtland H.W., Jepsen K.J., Kirby A., Kulbokas E.J., Daly M.J., Broman K.W., Lander E.S., Nadeau J.H. Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(50):19910-19914.
17. Erwin D.H., Davidson E.H. The evolution of hierarchical gene regulatory networks. Nat. Rev. Genet. 2009, 10(2):141-148.
18. Cowley A.W. Genomics and homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284(3):R611-R627.
19. Cookson W., Liang L., Abecasis G., Moffatt M., Lathrop M. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 2009, 10(3):184-194.
20. Williams S.M., Haines J.L., Moore J.H. The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?. Bioessays 2004, 26(2):170-179.
21. Tischler J., Lehner B., Fraser A.G. Evolutionary plasticity of genetic interaction networks. Nat. Genet. 2008, 40(4):390-391.
22. Dixon S.J., Fedyshyn Y., Koh J.L., Prasad T.S., Chahwan C., Chua G., Toufighi K., Baryshnikova A., Hayles J., Hoe K.L., Kim D.U., Park H.O., Myers C.L., Pandey A., Durocher D., Andrews B.J., Boone C. Significant conservation of synthetic lethal genetic interaction networks between distantly related eukaryotes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(43):16653-16658.
23. Bell R., Hubbard A., Chettier R., Chen D., Miller J.P., Kapahi P., Tarnopolsky M., Sahasrabuhde S., Melov S., Hughes R.E. A human protein interaction network shows conservation of aging processes between human and invertebrate species. PLoS Genet. 2009, 5(3):e1000414.
24. Sommer R.J. Homology and the hierarchy of biological systems. Bioessays 2008, 30(7):653-658.
25. Knight C.G., Pinney J.W. Making the right connections: biological networks in the light of evolution. Bioessays 2009, 31(10):1080-1090.
26. Tyler A.L., Asselbergs F.W., Williams S.M., Moore J.H. Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. Bioessays 2009, 31(2):220-227.
27. Gross F., Schaechtelin G., Brunner H., Peters G. The role of the Renin-Angiotensin System in blood pressure regulatin and kidney function. Can. Med. Assoc. J. 1964, 90:258-262.
28. Guyton A.C., Coleman T.G., Granger H.J. Circulation: overall regulation. Am. J. Physiol. 1972, 34:13-46.
29. Laragh J.H. Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Fed. Proc. 1967, 26:39-41.
30. Beevers D.G., Brown J.J., Fraser R., Lever A.F., Morton J.J., Robertson J.I., Semple P.F., Tree M. The clinical value of renin and angiotensin estimations. Kidney Int. Suppl. 1975, S181-S201.
31. Haber E. George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis. Circulation 1976, 54:849-861.
32. Bianchi G., Fox U., Pagetti D., Caravaggi A.M., Baer P.G., Baldoli E. Mechanisms involved in renal hypertension. Kidney Int. Suppl. 1975, S165-S173.
33. Ledingham J.M., Cohen R.D. Changes in the extracellular fluid volume and cardiac output during the development of experimental renal hypertension. Can. Med. Assoc. J. 1964, 90:292-294.
34. Bianchi G., Tenconi L.T., Lucca R. Effect in the conscious dog of constriction of the renal artery to a sole remaining kidney on haemodynamics, sodium balance, body fluid volumes, plasma renin concentration and pressor responsiveness to angiotensin. Clin. Sci. 1970, 38(6):741-766.
35. Ferrario C.M. Contribution of cardiac output and peripheral resistance to experimental renal hypertension. Am. J. Physiol. 1974, 226(3):711-717.
36. Schultze G., Kirsch K., Preu K., Lohmann F.W., Stolpmann H.J., Gotzen R., Dibmann T.H. Hamodinamik, Fiussigkeitshaushalt, plasmarenin und plasmakatecholamine in unterschiedlichen phasen der renovaskularen hypertonic des schales. Verh. Dtsch. Ges. Kreisl. Forsch 1973, 38:1-11.
37. Liard J.F., Cowley A.W., McCaa R.E., McCaa C.S., Guyton A.C. Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ. Res. 1974, 34(4):549-560.
38. Gutmann F.D., Tagawa H., Haber E., Barger A.C. Renal arterial pressure, renin secretion, and blood pressure control in trained dogs. Am. J. Physiol. 1973, 224(1):66-72.
39. Guyton A.C., Coleman T.G., Cowley A.V., Scheel K.W., Manning R.D., Norman R.A. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am. J. Med. 1972, 52:584-594.
40. Davis J.O. The pathogenesis of chronic renovascular hypertension. Circ. Res. 1977, 40:439-444.
41. Ledingham J.M., Cohen R.D. Circulatory changes during the reversal of experimental hypertension. Clin. Sci. 1962, 22:69-77.
42. Funder J.W., Blair-West J.R., Cain M.C., Catt K.J., Coghlan J.P., Denton D.A., Nelson J.F., Scoggins B.A., Wright R.D. Circulatory and humoral changes in the reversal of renovascular hypertension in sheep by unclipping the renal artery. Circ. Res. 1970, 27(2):249-258.
43. Edmunds M.E., Russell G.I., Bing R.F. Reversal of experimental renovascular hypertension. J. Hypertens. 1991, 9:289-301.
44. Bianchi G., Baer P.G., Fox U., Duzzi L., Pagetti D., Giovannetti A.M. Changes in renin, water balance, and sodium balance during development of high blood pressure in genetically hypertensive rats. Circ. Res. 1975, 36:153-161.
45. Lund-Johansen P., Omvik P. Hemodynamic patterns of untreated hypertensive disease. Hypertension: pathophysiology, diagnosis, and management, Chapter 22 1990, Raven Press Ltd. J.H. Laragh, B.M. Brenner (Eds.).
46. de Leeuw P.W., Birkenhäger W.H. The renal circulation in essential hypertension. J. Hypertens. 1983, 1:321-331.
47. Bianchi G., Cusi D., Barlassina C., Lupi G.P., Ferrari P., Picotti G.B., Gatti M., Polli E. Renal dysfunction as a possible cause of essential hypertension in predisposed subjects. Kidney Int. 1983, 23:870-875.
48. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
49. Shimkets R.A., Warnock D.G., Bositis C.M., Nelson-Williams C., Hansson J.H., Schambelan M., Gill J.R., Ulick S., Milora R.V., Findling J.W., et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79:407-414.
50. Lifton R.P. Genetic determinants of human hypertension. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8545-8551.
51. Thomson S.C., Blantz R.C. Glomerulotubular balance, tubuloglomerular feedback, and salt homeostasis. J. Am. Soc. Nephrol. 2008, 19:2272-2275.
52. Schnermann J., Briggs J.P. Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice. Kidney Int. 2008, 74:418-426.
53. Grünberger C., Obermayer B., Klar J., Kurtz A., Schweda F. The calcium paradoxon of renin release: calcium suppresses renin exocytosis by inhibition of calcium-dependent adenylate cyclases AC5 and AC6. Circ Res. 2006, 99:1197-1206.
54. Williams S.M., Ritchie M.D., Phillips J.A., Dawson E., Prince M., Dzhura E., Willis A., Semenya A., Summar M., White B.C., Addy J.H., Kpodonu J., Wong L.J., Felder R.A., Jose P.A., Moore J.H. Multilocus analysis of hypertension: a hierarchical approach. Hum. Hered. 2004, 57(1):28-38.
55. Buchanan A.V., Sholtis S., Richtsmeier J., Weiss K.M. What are genes "for" or where are traits "from"? What is the question?. Bioessays 2009, 31(2):198-208.
56. Miller E.D., Samuels A.I., Haber E., Barger A.C. Inhibition of angiotensin conversion in experimental renovascular hypertension. Science 1972, 177(54):1108-1109.
57. Davis J.O., Freeman R.H., Johnson J.A., Spielman W.S. Agents which block the action of the renin-angiotensin system. Circ. Res. 1974, 34(3):279-285.
58. Brunner H.R., Kirshman J.D., Sealey J.E., Laragh J.H. Hypertension of renal origin: evidence for two different mechanisms. Science 1971, 174:1344-1346.
59. Swales J.D., Thurston H. Sodium restriction and inhibition of the renin-angiotensin system in renovascular hypertension in the rat. Clin. Sci. Mol. Med. 1977, 52:371-375.
60. Watkins B.E., Davis J.O., Freeman R.H., DeForrest J.M., Stephens G.A. Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog. Circ. Res. 1978, 42:813-821.
61. Hofbauer K.G., Huppertz C. Pharmacotherapy and evolution. Trends Ecol. Evol. 2002, 17:328-334.
62. Ebrahim S., Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?. Hum. Genet. 2008, 123:15-33.
63. Kamstrup P.R., Tybjaerg-Hansen A., Steffensen R., Nordestgaard B.G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009, 301:2331-2339.
64. Thanassoulis G., O'Donnell C.J. Mendelian randomization: nature's randomized trial in the post-genome era. JAMA 2009, 301:2386-2388.
65. Tishkoff S.A., Reed F.A., Ranciaro A., Voight B.F., Babbitt C.C., Silverman J.S., Powell K., Mortensen H.M., Hirbo J.B., Osman M., Ibrahim M., Omar S.A., Lema G., Nyambo T.B., Ghori J., Bumpstead S., Pritchard J.K., Wray G.A., Deloukas P. Convergent adaptation of human lactase persistence in Africa and Europe. Nat. Genet. 2007, 39:31-40.
66. Ferrandi M., Molinari I., Barassi P., Minotti E., Bianchi G., Ferrari P. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J. Biol. Chem. 2004, 279:33306-33314.
67. Schoner W., Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am. J. Cardiovasc. Drugs 2007, 7:173-189. (Review).
68. Zhang J., Lee M.Y., Cavalli M., Chen L., Berra-Romani R., Balke C.W., Bianchi G., Ferrari P., Hamlyn J.M., Iwamoto T., Lingrel J.B., Matteson D.R., Wier W.G., Blaustein M.P. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J. Physiol. 2005, 569(Pt 1):243-256.
69. Manunta P., Maillard M., Tantardini C., Simonini M., Lanzani C., Citterio L., Stella P., Casamassima N., Burnier M., Hamlyn J.M., Bianchi G. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J. Hypertens. 2008, 26(5):914-920.
70. Manunta P., Lavery G., Lanzani C., Braund P.S., Simonini M., Bodycote C., Zagato L., Delli Carpini S., Tantardini C., Brioni E., Bianchi G., Samani N.J. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 2008, 52:366-372.
71. Efendiev R., Krmar R.T., Ogimoto G., Zwiller J., Tripodi G., Katz A.I., Bianchi G., Pedemonte C.H., Bertorello A.M. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+, K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ. Res. 2004, 95:1100-1108.
72. Ferrandi M., Tripodi G., Salardi S., Florio M., Modica R., Barassi P., Parenti P., Shainskaya A., Karlish S., Bianchi G., Ferrari P. Renal Na, K-ATPase in genetic hypertension. Hypertension 1996, 28:1018-1025.
73. Manunta P., Burnier M., D'Amico M., Buzzi L., Maillard M., Barlassina C., Lanella G., Cusi D., Bianchi G. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 1999, 33:694-697.
74. Manunta P., Cusi D., Barlassina C., Righetti M., Lanzani C., D'Amico M., Buzzi L., Citterio L., Stella P., Rivera R., Bianchi G. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int. Jun 1998, 53(6):1471-1478.
75. Glorioso N., Manunta P., Filigheddu F., Troffa C., Stella P., Barlassina C., Lombardi C., Soro A., Dettori F., Parpaglia P.P., Alibrandi M.T., Cusi D., Bianchi G. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 1999, 34(4 Pt 1):649-654.
76. Chu S.L., Zhu D.L., Xiong M.M., Wang G.L., Zhang W.Z., Zhou H.F., Shen D., Gao P.J., Zhan Y.M., Jin L. Linkage analysis of twelve candidate gene loci regulating water and sodium metabolism and membrane ion transport in essential hypertension. Hypertens. Res. 2002, 25(4):635-639.
77. He X., Wang G., Huang W., Ding-Liang Z. Linkage analysis of five candidate genes and essential hypertension in 106 Chinese nuclear families. J. Hum. Hypertens. 2003, 17:69-72.
78. He X., Zhu D.L., Chu S.L., Jin L., Xiong M.M., Wang G.L., Zhang W.Z., Zhou H.F., Mao S.Y., Zhan Y.M., Zhuang Q.N., Liu X.M., Zhao Y., Huang W. alpha-Adducin gene and essential hypertension in China. Clin. Exp. Hypertens. 2001, 23(7):579-589.
79. Lu L.H., Chen H., Yu L. Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008, 25(2):132-135.
80. Gong P.Y., Shen G.M., Peng H.M., Luo Y., Shen Y., Zhao X. Association of the polymorphisms of sodium transport related genes with essential hypertension. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009, 26(1):91-94.
81. Ju Z., Zhang H., Sun K., Song Y., Lu H., Hui R., Huang X. Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: a case-control and family-based study. J. Hypertens. 2003, 21(10):1861-1868.
82. Guo H.F., Li Y., Wang G.L., Lu Y.G., Zhou H.F., Gao P.J., Zhu D.L., Wang J.G. Association of peripheral and central blood pressure with the alpha-adducin Gly460Trp polymorphism in a Chinese population. Zhonghua Xin Xue Guan Bing Za Zhi 2005, 33(7):608-612.
83. Niu W.Q., Zhang Y., Ji K.D., Gao P.J., Zhu D.L. Lack of association between alpha-adducin G460W polymorphism and hypertension: evidence from a case-control study and a meta-analysis. J. Hum. Hypertens. 2009, 1-8.
84. Shin M.H., Chung E.K., Kim H.N., Park K.S., Nam H.S., Kweon S.S., Choi J.S. Alpha-adducin Gly460Trp polymorphism and essential hypertension in Korea. J. Korean Med. Sci. Dec 2004, 19(6):812-814.
85. Wang J.G., Liu L., Zagato L., Xie J., Fagard R., Jin K., Wang J., Li Y., Bianchi G., Staessen J.A., Liu L. Blood pressure in relation to three candidate genes in a Chinese population. J. Hypertens. 2004, 22(5):937-944.
86. Dou X.F., Zhang H.Y., Huang X.H., Liu X.N., Ju Z.Y., Sun K., Wang D.W., Liao Y.H., Ma A.Q., Zhu Z.M., Zhao B.R., Zhao J.Z., Song Y., Zhang L., Hui R.T. Alpha-adducin gene G/W460 polymorphism is associated with intracerebral hemorrhage in Chinese. Zhonghua Yi Xue Za Zhi Feb 2 2004, 84(3):186-188. (Chinese).
87. Wu S.L., Li D.Q., Li H.F., Yu Q., Li Y., Zhao H.Y. Association of polymorphism in alpha-adducin gene with antihypertensive effect of Hydrochlorothiazide, Zhao. Zhonghua Xin Xue Guan Bing Za Zhi 2005, 33(10):880-884.
88. Kelly T.N., Rice T.K., Gu D., Hixson J.E., Chen J., Liu D., Jaquish C.E., Bazzano L.A., Hu D., Ma J., Gu C.C., Huang J., Hamm L.L., He J. Novel genetic variants in the alpha-adducin and guanine nucleotide binding protein beta-polypeptide 3 genes and salt sensitivity of blood pressure. Am. J. Hypertens. Sep 2009, 22(9):985-992.
89. Song X.Y., Lee S.Y., Ma R.C., So W.Y., Cai J.H., Tam C., Lam V., Ying W., Ng M.C., Chan J.C. Phenotype-genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling. Diabetologia 2009, 52(8):1543-1553.
90. Kato N., Sugiyama T., Nabika T., Morita H., Kurihara H., Yazaki Y., Yamori Y. Lack of association between the alpha-adducin locus and essential hypertension in the Japanese population. Hypertension 1998, 31(3):730-733.
91. Ishikawa K., Katsuya T., Sato N., Nakata Y., Takami S., Takiuchi S., Fu Y., Higaki J., Ogihara T. No association between alpha-adducin 460 polymorphism and essential hypertension in a Japanese population. Am. J. Hypertens. 1998, 11(4 Pt 1):502-506.
92. Iwai N., Tamaki S., Nakamura Y., Kinoshita M. Polymorphism of alpha-adducin and hypertension. Lancet 1997, 350(9074):369.
93. Shioji K., Kokubo Y., Mannami T., Inamoto N., Morisaki H., Mino Y., Tagoi N., Yasui N., Iwaii N. Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens. Res. 2004, 27(1):31-37.
94. Nakamura Y., Tabara Y., Miki T., Tamaki S., Kita Y., Okamura T., Ueshima H. Both angiotensinogen M235T and alpha-adducin G460W polymorphisms are associated with hypertension in the Japanese population. J. Hum. Hypertens. 2007, 21(3):253-255.
95. Watanabe Y., Metoki H., Ohkubo T., Katsuya T., Tabara Y., Kikuya M., Hirose T., Sugimoto K., Asayama K., Inoue R., Hara A., Obara T., Nakura J., Kohara K., Totsune K., Ogihara T., Rakugi H., Miki T., Imai Y. Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study. Hypertens. Res. 2010, 33(2):129-134.
96. Yamagishi K., Iso H., Tanigawa T., Cui R., Kudo M., Shimamoto T. Alpha-adducin G460W polymorphism, urinary sodium excretion, and blood pressure in community-based samples. Am. J. Hypertens. 2004, 17(5 Pt 1):385-390.
97. Sugimoto K., Hozawa A., Katsuya T., Matsubara M., Ohkubo T., Tsuji I., Motone M., Higaki J., Hisamachi S., Imai Y., Ogihara T. alpha-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. J. Hypertens. 2002, 20(9):1779-1784.
98. Tamaki S., Nakamura Y., Tabara Y., Okamura T., Kita Y., Kadowaki T., Tsujita Y., Horie M., Miki T., Ueshima H. Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample: The Shigaraki Study. Hypertens. Res. 2005, 28(8):645-650.
99. Narita I., Goto S., Saito N., Song J., Ajiro J., Sato F., Saga D., Kondo D., Akazawa K., Sakatsume M., Gejyo F. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 2003, 42(3):304-309.
100. Kato N., Miyata T., Tabara Y., Katsuya T., Yanai K., Hanada H., Kamide K., Nakura J., Kohara K., Takeuchi F., Mano H., Yasunami M., Kimura A., Kita Y., Ueshima H., Nakayama T., Soma M., Hata A., Fujioka A., Kawano Y., Nakao K., Sekine A., Yoshida T., Nakamura Y., Saruta T., Ogihara T., Sugano S., Miki T., Tomoike H. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Hum. Mol. Genet. 2008, 17(4):617-627.
101. Zhou X., Tang W., Wu H., Cun Y., Yang Y., Zhang J., Yu H., Li K., He L., Xiao C. Are the beta-adducin C1797T polymorphism and gamma-adducin A386G polymorphism associated with essential hypertension in Yi and Hani populations?. Clin. Chim. Acta. 2006, 374(1-2):153-154.
102. Wang J.G., Staessen J.A., Barlassina C., Fagard R., Kuznetsova T., Struijker-Boudier H.A., Zagato L., Citterio L., Messaggio E., Bianchi G. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Kidney Int. 2002, 62(6):2152-2159.
103. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361:865-872. (Review).
104. Freedman M.L., Reich D., Penney K.L., McDonald G.J., Mignault A.A., Patterson N., Gabriel S.B., Topol E.J., Smoller J.W., Pato C.N., Pato M.T., Petryshen T.L., Kolonel L.N., Lander E.S., Sklar P., Henderson B., Hirschhorn J.N., Altshuler D. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 2004, 36:388-393.
105. Cardon L.R., Palmer L.J. Population stratification and spurious allelic association. Lancet 2003, 361:598-604. (Review).
106. Lazzeroni L.C., Karlovich C.A. Genotype to phenotype: associations, errors and complexity. Trends Genet. 2002, 18:283-284.
107. Staessen J.A., Wang J.G., Brand E., Barlassina C., Birkenhäger W.H., Herrmann S.M., Fagard R., Tizzoni L., Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J. Hypertens. 2001, 19(8):1349-1358.
108. Wang J.G., Staessen J.A., Tizzoni L., Brand E., Birkenhäger W.H., Fagard R., Herrmann S.M., Bianchi G. Renal function in relation to three candidate genes. Am. J. Kidney Dis. 2001, 38(6):1158-1168.
109. Balkestein E.J., Staessen J.A., Wang J.G., van Der Heijden-Spek J.J., Van Bortel L.M., Barlassina C., Bianchi G., Brand E., Herrmann S.M., Struijker-Boudier H.A. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001, 38(5):1190-1197.
110. Balkestein E.J., Wang J.G., Struijker-Boudier H.A., Barlassina C., Bianchi G., Birkenhäger W.H., Brand E., Den Hond E., Fagard R., Herrmann S.M., Van Bortel L.M., Staessen J.A. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J. Hypertens. 2002, 20(8):1551-1561.
111. Seidlerova J., Staessen J.A., Nawrot T., Brand E., Brand-Herrmann S.M., Casamassima N., Citterio L., Hasenkamp S., Kuznetsova T., Li Y., Manunta P., Richart T., Struijker-Boudier H.A., Fagard R., Filipovsky J. Arterial properties in relation to genetic variation in alpha-adducin and the renin-angiotensin system in a white population. J. Hum. Hypertens. 2009, 23:55-64.
112. Seidlerová J., Staessen J.A., Bochud M., Nawrot T., Casamassima N., Citterio L., Kuznetsova T., Jin Y., Manunta P., Richart T., Struijker-Boudier H.A., Fagard R., Filipovskỳ J., Bianchi G. Arterial properties in relation to genetic variations in the adducin subunits in a white population. Am. J. Hypertens. 2009, 22(1):21-26.
113. Kuznetsova T., Citterio L., Herbots L., Carpini S.D., Thijs L., Casamassima N., Richart T., Fagard R.H., Bianchi G., Staessen J.A. Effects of genetic variation in adducin on left ventricular diastolic function as assessed by tissue Doppler imaging in a Flemish population. J. Hypertens. 2008, 26(6):1229-1236.
114. Cwynar M., Staessen J.A., Tichá M., Nawrot T., Citterio L., Kuznetsova T., Wojciechowska W., Stolarz K., Filipovskỳ J., Kawecka-Jaszcz K., Grodzicki T., Struijker-Boudier H.A., Thijs L., Van Bortel L.M., Bianchi G. European Project On Genes in Hypertension (EPOGH) Investigators, Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans. J. Hypertens. 2005, 23(5):961-969.
115. Kuznetsova T., Staessen J.A., Brand E., Cwynar M., Stolarz K., Thijs L., Tikhonoff V., Wojciechowska W., Babeanu S., Brand-Herrmann S.M., Casiglia E., Filipovskỳ J., Grodzicki T., Nikitin Y., Peleska J., Struijker-Boudier H., Bianchi G., Kawecka-Jaszcz K. European Project on Genes in Hypertension Investigators. Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. J. Hypertens. 2006, 24(2):235-242. (Review).
116. Tikhonoff V., Kuznetsova T., Stolarz K., Bianchi G., Casiglia E., Kawecka-Jaszcz K., Nikitin Y., Tizzone L., Wang J.G., Staessen J.A. beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations. Am. J. Hypertens. 2003, 16(10):840-846.
117. Tikhonoff V., Kuznetsova T., Stolarz K., Bianchi G., Casiglia E., Kawecka-Jaszcz K., Nikitin Y., Tizzone L., Wang J.G., Staessen J.A. European Project on Genes in Hypertension Investigators, Blood pressure phenotypes in relation to the beta-adducin C1797T polymorphism in the European Project on Genes in Hypertension (EPOGH). Blood Press. Monit. 2003, 8(4):151-154.
118. Manunta P., Ferrandi M., Bianchi G., Hamlyn J.M. Endogenous ouabain in cardiovascular function and disease. J. Hypertens. 2009, 27:9-18.
119. Wang J.G., Staessen J.A., Messaggio E., Nawrot T., Fagard R., Hamlyn J.M., Bianchi G., Manunta P. Salt, endogenous ouabain and blood pressure interactions in the general population. J. Hypertens. 2003, 21(8):1475-1481.
120. Li Y., Thijs L., Kuznetsova T., Zagato L., Struijker-Boudier H., Bianchi G., Staessen J.A. Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: a prospective population study. Hypertension 2005, 46(3):527-532.
121. Li Y., Zagato L., Kuznetsova T., Tripodi G., Zerbini G., Richart T., Thijs L., Manunta P., Wang J.G., Bianchi G., Staessen J.A. Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension 2007, 49(6):1291-1297.
122. Cook N.R. Salt intake, blood pressure and clinical outcomes. Curr. Opin. Nephrol. Hypertens. 2008, 17:310-314.
123. Sanders P.W. Dietary salt intake, salt sensitivity, and cardiovascular health. Hypertension 2009, 53:442-445.
124. Polichnowski A.J., Cowley A.W. Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension 2009, 54:1269-1277.
125. Bagrov A.Y., Shapiro J.I. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat. Clin. Pract. Nephrol. 2008, 4:378-392.
126. Psaty B.M., Doggen C., Vos H.L., Vandenbroucke J.P., Rosendaal F.R. Association of the alpha-adducin polymorphism with blood pressure and risk of myocardial infarction. J. Hum. Hypertens. 2000, 14(2):95-97.
127. Morrison A.C., Bray M.S., Folsom A.R., Boerwinkle E. ADD1 460W Allele Associated With Cardiovascular Disease in Hypertensive Individuals. Hypertension 2002, 39:1053-1057.
128. Psaty B.M., Smith N.L., Heckbert S.R., Vos H.L., Lemaitre R.N., Reiner A.P., Siscovick D.S., Bis J., Lumley T., Longstreth W.T., Rosendaal F.R. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA 2002, 287:1680-1689.
129. Dou X.F., Zhang H.Y., Huang X.H., Liu X.N., Ju Z.Y., Sun K., Wang D.W., Liao Y.H., Ma A.Q., Zhu Z.M., Zhao B.R., Zhao J.Z., Song Y., Zhang L., Hui R.T. Alpha-adducin gene G/W460 polymorphism is associated with intracerebral hemorrhage in Chinese. Zhonghua Yi Xue Za Zhi Feb 2 2004, 84(3):186-188. (Chinese).
130. van Rijn M.J., Bos, Yazdanpanah M., Isaacs A., Arias-Vásquez A., Koudstaal P.J., Hofman A., Witteman J.C., van Duijn C.M., Breteler M.M. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk. Stroke 2006, 37(12):2930-2934.
131. Yazdanpanah M., Sayed-Tabatabaei F.A., Hofman A., Aulchenko Y.S., Oostra B.A., Stricker B.H., Pols H.A., Lamberts S.W., Witteman J.C., Janssen J.A., van Duijn C.M. The alpha-adducin gene is associated with macrovascular complications and mortality in patients with type 2 diabetes. Diabetes 2006, 55(10):2922-2927.
132. Cha S.H., Kim H.T., Jang Y., Park S., Kim J.J., Song M.Y., Park J.H., Ryu H.J., Park H.Y., Yoon S.J., Kimm K., Lee J.K., Oh B. Association of alpha-adducin Gly460Trp polymorphism with coronary artery disease in a Korean population. J. Hypertens. 2007, 25(12):2413-2420.
133. Zafarmand M.H., van der Schouw Y.T., Grobbee D.E., de Leeuw P.W., Bots M.L. Alpha-adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women. Hypertension 2008, 51(6):1665-1670.
134. Gerhard T., Gong Y., Beitelshees A.L., Mao X., Lobmeyer M.T., Cooper-DeHoff R.M., Langaee T.Y., Schork N.J., Shriver M.D., Pepine C.J., Johnson J.A. Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES) Am. Heart J. 2008, 156(2):397-404. INVEST Investigators.
135. Plat A.W., Stoffers H.E., de Leeuw P.W., van Schayck C.P., Soomers F.L., Kester A.D., Aretz K., Kroon A.A. The association between arterial stiffness and the angiotensin II type 1 receptor (A1166C) polymorphism is influenced by the use of cardiovascular medication. J. Hypertens. 2009, 27(1):69-75.
136. Plat A.W., Stoffers H.E., de Leeuw P.W., van Schayck C.P., Soomers F.L., Kester A.D., Aretz K., Kroon A.A. Sex-specific effect of the alpha-adducin (G460W) and AGTR1 (A1166C) polymorphism on carotid intima-media thickness. J. Hypertens. 2009, 27(11):2165-2173.
137. Plat A.W., Stoffers H.E., Klungel O.H., van Schayck C.P., de Leeuw P.W., Soomers F.L., Schiffers P.M., Kester A.D., Kroon A.A. The contribution of six polymorphisms to cardiovascular risk in a Dutch high-risk primary care population: the HIPPOCRATES project. J. Hum. Hypertens. 2009, 23(10):659-667.
138. Plat A.W., Stoffers H.E., de Leeuw P.W., van Schayck C.P., Soomers F.L., Kester A.D., Aretz K., Kroon A.A. The influence of six cardiovascular polymorphisms on a first event of ischemic heart disease is modified by sex and age. Coron. Artery Dis. 2009, 20(8):499-505.
139. Tobin M.D., Braund P.S., Burton P.R., Thompson J.R., Steeds R., Channer K., Cheng S., Lindpaintner K., Samani N.J. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur. Heart J. 2004, 25(6):459-467.
140. van Wieren-de Wijer D.B., Maitland-van der Zee A.H., de Boer A., Kroon A.A., de Leeuw P.W., Schiffers P., Janssen R.G., Psaty B.M., van Duijn C.M., Stricker B.H., Klungel O.H. Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. J. Hypertens. 2009, 27(1):61-68.
141. Schelleman H., Klungel O.H., Witteman J.C., Breteler M.M., Hofman A., van Duijn C.M., de Boer A., Stricker B.H. Diuretic-gene interaction and the risk of myocardial infarction and stroke. Pharmacogenomics J. 2007, 7(5):346-352.
142. Schelleman H., Stricker B.H., Verschuren W.M., de Boer A., Kroon A.A., de Leeuw P.W., Kromhout D., Klungel O.H. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics J. 2006, 6(1):22-26.
143. Bozkurt O., de Boer A., Grobbee D.E., de Leeuw P.W., Kroon A.A., Schiffers P., Klungel O.H. Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diuretics. Am. J. Hypertens. 2009, 22(5):545-551.
144. van Rijn M.J., Schut A.F., Aulchenko Y.S., Deinum J., Sayed-Tabatabaei F.A., Yazdanpanah M., Isaacs A., Axenovich T.I., Zorkoltseva I.V., Zillikens M.C., Pols H.A., Witteman J.C., Oostra B.A., van Duijn C.M. Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes. J. Hypertens. 2007, 25(3):565-570.
145. Cusi D., Barlassina C., Azzani T., Casari G., Citterio L., Devoto M., Glorioso N., Lanzani C., Manunta P., Righetti M., Rivera R., Stella P., Troffa C., Zagato L., Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349(9062):1353-1357.
146. Sciarrone M.T., Stella P., Barlassina C., Manunta P., Lanzani C., Bianchi G., Cusi D. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003, 41(3):398-403.
147. Turner S.T., Chapman A.B., Schwartz G.L., Boerwinkle E. Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am. J. Hypertens. 2003, 16(10):834-839.
148. Schelleman H., Klungel O.H., Witteman J.C., Hofman A., van Duijn C.M., de Boer A., Stricker B.H. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Eur. J. Hum. Genet. 2006, 14(7):860-866.
149. Matayoshi T., Kamide K., Takiuchi S., Yoshii M., Miwa Y., Takami Y., Tanaka C., Banno M., Horio T., Nakamura S., Nakahama H., Yoshihara F., Inenaga T., Miyata T., Kawano Y. The thiazide-sensitive Na(+)-Cl(-) cotransporter gene, C1784T, and adrenergic receptor-beta3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics. Hypertens. Res. 2004 Nov, 27(11):821-833.
150. Davis B.R., Arnett D.K., Boerwinkle E., Ford C.E., Leiendecker-Foster C., Miller M.B., Black H., Eckfeldt J.H. Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study. Pharmacogenomics J. 2007, 7(2):112-122.
151. Suonsyrjä T., Hannila-Handelberg T., Fodstad H., Donner K., Kontula K., Hiltunen T.P. Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES Study. Am. J. Hypertens 2009, 22:169-175.
152. Staessen J.A., Kuznetsova T., Acceto R., Bacchieri A., Brand E., Burnier M., Celis H., Citterio L., de Leeuw P.W., Filipovsky J., Fournier A., Kawecka-Jaszcz K., Manunta P., Nikitin Y., O'Brien E.T., Redon J., Thijs L., Ferrari P., Valentini G., Bianchi G. OASIS-HT: design of a pharmacogenomic dose-finding study. Pharmacogenomics 2005, 6:755-775.
153. Fletcher A.E., Franks P.J., Bulpitt C.J. The effect of withdrawing antihypertensive therapy: a review. J. Hypertens. 1988, 6:431-436.
154. Levinson P.D., Khatri I.M., Freis E.D. Persistence of normal BP after withdrawal of drug treatment in mild hypertension. Arch. Intern. Med. 1982, 142:2265-2268.
155. Takata Y., Yoshizumi T., Ito Y., Ueno M., Tsukashima A., Iwase M., Kobayashi K., Fujishima M. Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting enzyme inhibitors in essential hypertensives. Am. Heart J. 1992, 124:1574-1580.
156. Blaufox M.D., Langford H.G., Oberman A., Hawkins C.M., Wassertheil-Smoller S.W., Cutter G.R. Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension. J. Hypertens. Suppl. 1984, 2:S179-S181.
157. Ho G.Y., Blaufox M.D., Wassertheil-Smoller S., Oberman A., Langford H. Plasma renin predicts success of antihypertensive drug withdrawal. Am. J. Hypertens. 1994, 7:679-684.
158. Swart S., Bing R.F., Swales J.D., Thurston H. Plasma renin in long-term diuretic treatment of hypertension: effect of discontinuation and restarting therapy. Clin. Sci. (Lond.) 1982, 63:121-125.
159. Zanchetti A., Mancia G. The dilemma of placebo controlled studies: scientific evidence, guidelines, ethics and regulatory recommendations. J. Hypertens. 2009, 27:1-2.
160. Dukacz S.A., Adams M.A., Kline R.L. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats. Am. J. Physiol. 1997, 273:F104-F112.
161. Liang M., Lee N.H., Wang H., Greene A.S., Kwitek A.E., Kaldunski M.L., Luu T.V., Frank B.C., Bugenhagen S., Jacob H.J., Cowley A.W. Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats. Physiol. Genomics 2008, 34:54-64.
162. Lu L., Li P., Yang C., Kurth T., Misale M., Skelton M., Moreno C., Roman R.J., Greene A.S., Jacob H.J., Lazar J., Liang M., Cowley A.W. Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol. Genomics 2010, 41:63-70.
163. Hopkins A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 2008, 4:682-690.
164. Vallance P., Levick M. Drug discovery and development in the age of molecular medicine. Clin. Pharmacol. Ther. 2007, 82:363-366.